baber/WOPTO huggingface dataset:
Patent NZ-331364-A (NZ)
Title: Thermal power machine having a moving regenerator
Inventor: OBERMOSER KARL
IPC: F02G1/043
Filed: 1997-04-10
Abstract: The invention relates to a thermal machine having a housing (2) which defines an operating space, an operating medium which is contained in the operating space, a heat source (6) which is arranged in the housing (2) as well as a heat sink (5) which is arranged in the housing (2), a regenerator (7) which forms an intermediate heat store which is mounted such that it can move linearly in the operating space, and at least one operating piston (not shown) which is acted on by the operating medium, for outputting mechanical power from the operating space, and for coupling mechanical power into the operating space. The invention provides that the operating piston  is arranged in or on the housing (2) such that its compression movement is associated with a volume flow of the operating medium from the heat source to the heat sink, and its expansion movement is associated with a volume flow in the reverse direction, and the force resulting from the volume flow is used to drive the regenerator (7).
Patent NZ-332276-A (NZ)
Title: Oil enrobed par-fried potato strips comprising 8 to 30% total fat
Inventor: ELSEN JOSEPH JAMES
IPC: A23L19/18
Filed: 1997-04-16
Abstract: Oil enrobed par-fried potato strips suitable for oven finishing comprise par-fried potato strips having from 34 % to 58 % bulk moisture and from 8% to 30 % fat.  The par-fried potato strips have a substantially uniform surface coating of oil or fat.  The surface coating comprises from 2 % to 15 % by weight of the par-fried potato strips.  When oven finished, the oil enrobed par-fried potato strips have substantially the same taste, quality and characteristics as French fries that have been deep fried, it is stated.  The par-fried potato strips may be frozen.  The fat may be a flavoured or conditioned oil.
Patent NZ-334607-A (NZ)
Title: Wound dressing comprising a backing layer bearing a reference marking, a hydrocolloid layer and a release layer
Inventor: KADASH MARJORY
IPC: A61L15/60
Filed: 1997-09-22
Abstract: An improved wound dressing is provided which comprises a backing layer bearing a reference marking, a hydrocolloid layer and a release layer.  The hydrocolloid swells in use.  This swelling can be seen or felt through the backing layer.  When the swelling extends to or beyond the reference marking, the dressing should be changed to prevent leaking.  Thus, the dressing can be left in place for as long as possible, but not so long as to damage the underlying skin.
Patent NZ-336083-A (NZ)
Title: Adhesives having a microreplicated topography with a contact area of at least 35%, preferably 85-96% to provide for adequate fluid egress without adversely affecting adhesion to the supporting substrate
Inventor: SHER FRANK T
IPC: C09J7/38
Filed: 1997-05-30
Abstract: Adhesives having a microreplicated topography are prepared from contacting a microembossed pattern which is a surface having an effective 3-D pattern that generates a maximum difference of less than 45 mm to a layer of adhesive. When an adhesion interface is established between the layer of adhesive and a supporting substrate, the topography of the adhesive surface controls the performance of the adhesion interface. The adhesive has a contact area of at least 35%. Articles having microreplicated adhesive surfaces are also disclosed that have an advantage of providing microchannels for fluids egress for an effective period of time. Multiple microembossed patterns produce microreplicated adhesive surfaces having both microchannels for fluid egress and pegs for improved adhesive properties.
Patent NZ-336378-A (NZ)
Title: Use of hydroxyguanidines for treatment and prevention of ischemic disease in particular hydroxyguanidine substituted with 4-methoxy-phenyl group
Inventor: WIKBERG JARL
IPC: A01N1/02
Filed: 1997-11-21
Abstract: Hydroxyguanidines shown as Formula (I) are useful in the treatment or prevention of an ischemic disease condition including an ischemic condition caused by surgery or other therapy and being associated with the production of oxygen derived radicals. The disease condition being a xanthine oxidase/xanthine dehydrogenase mediated ischemic condition selected from heart infarction, angina pectoris, cerebrovascular infarction, circulatory shock, transient ischemic attacks of the cerebrovascular system, arterial occlusion, arterial thromboembolism, bowel torsion with strangulation, testicular torsion, lung embolus, cardiac surgery including by-pass grafting, and localised organ surgery involving reduced blood flow, organ transplantation, circulatory shock, and general hypoxia. Preferred hydroxyguanidines are carbimino hydroxyguanidines, in particular aryl carbimino hydroxyguanidines. Wherein; R1 is -N=CR3R4; R2 is selected from hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkenyl, cycloheteroalkyl, cycloalkenyl, cycloheteroalkenyl, alkynyl, aryl, heteroaryl, a carbon atom or heteroatom connected to R3, and a single bond of R3; R3 and R4 are selected independently of each other from the group consisting of H, alkyl, alkenyl, cycloalkyl, cycloalkenyl, cycloheteroalkyl, cycloheteroalkenyl, alkynyl, aryl, heteroaryl, and a bridge of from 4 to 5 carbon or heteroatoms forming a 5- or 6-membered ring which is optionally fused with cycloalkyl, cycloheteroalkyl, cycloalkenyl, cycloheteroalkenyl, aryl or heteroaryl, and wherein R3, in addition, is selected from a single bond of R2 and a carbon or hetero atom connected to R2 such as to form a 6-or 5-membered ring which is optionally fused with cycloalkyl, cycloheteroalkyl, cycloalkenyl, cycloheteroalkenyl, aryl or heteroaryl; and wherein optionally one or several hydrogen(s) in R2, R3, R4 are independently exchanged for alkyl, alkenyl, cycloalkyl, cycloheteroalkyl, cycloalkenyl, cycloheteroalkenyl, alkynyl, aryl, heteroaryl, halogen or functional group, and wherein one or more hydrogen(s) in alkyl, alkenyl, cycloalkyl, cycloheteroalkyl, cycloalkenyl, cycloheteroalkenyl, alkynyl, aryl, heteroaryl, functional group are optionally independently exchanged for halogen or functional group.
Patent NZ-505351-A (NZ)
Title: Sustained release water-insoluble matrix comprising protein crosslinked with urea using a crosslinking agent and a bioactive substances such as a trace element
Inventor: SILCOCK PATRICK JOSEPH
IPC: A61K47/42
Filed: 1998-12-24
Abstract: A matrix that is substantially water-insoluble and is capable of effecting a slow release of an encapsulated bioactive substance. The matrix comprises a protein or protein-containing material cross-linked by a cross-linking agent to urea to form a 3-dimensional structure throughout which the bioactive substance is substantially uniformly dispersed. In preferred embodiments, the protein or protein-containing material is acid casein, and the bioactive substance is a trace element such as selenium or cobalt. A process of preparing this matrix is also described herein.
Patent NZ-505440-A (NZ)
Title: Alpha-aminoamide derivatives useful as analgesic agents
Inventor: VARASI MARIO
IPC: C07C255/54
Filed: 1998-12-12
Abstract: Compounds of formula (I) and (IA), alpha-aminoamides, having analgesic properties that are useful in treating and alleviating chronic and neuropathic pain are described. A is a -(CH2)m-, -(CH2)n-X- or -(CH2)v-O- group wherein m is an integer of 1 to 4, n is zero or an integer of 1 to 4, X is -S- or -NH-, and v is zero or an integer of 1 to 5; s is 1 or 2; R is a furyl, thienyl, or pyridyl ring of a phenyl ring; R1 is hydrogen or C1-C4 alkyl; one of R2 and R3 is hydrogen and the other is hydrogen or C1-C4 alkyl optionally substituted by hydroxy or phenyl; or R2 and R3 taken together with the carbon atom to which they are linked form a C3-C6 cycloalkyl ring; or R2 and R3 are both methyl; R4 is hydrogen or C1-C4 alkyl ring; or a pharmaceutically acceptable salt thereof; with the proviso that, when A is a -(CH2)5-O- group then s is 1, R is a phenyl group optionally substituted by one or two substituents  selected independently from halogen, trifluoromethyl and C1-C4 alkoxy, R1 is hydrogen and one of R2 and R3 is hydrogen and the other is hydrogen or C1-C4 alkyl optionally substituted hydroxy; and when R2 and R3 are both methyl the R is other than a furyl , thienyl or pyridyl ring. For compounds of formula (IA); A is a -(CH2)m-, -(CH2)n-E- group wherein m is an integer of 1 to 4, n is zero or an integer of 1 to 4, and E is -S- or -NH-; and one of R10 and R11 is cyano and the other is independently selected from hydrogen, halogen, cyano C1-C4 alkyl, C1-C4 alkoxy and trifluoromethyl.
Patent NZ-505757-A (NZ)
Title: Thioether furan nitrone compounds and pharmaceuticals thereof; useful for the treatment or prophylaxis of neurodegenerative, autoimmune and inflammatory conditions
Inventor: KELLEHER JUDITH A
IPC: A61P31/04
Filed: 1999-01-14
Abstract: A compound of formula I, wherein: R' is alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, aralkyl, aryl, cycloalkyl, cycloalkylalkyl or cycloalkenyl; R2 is alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, aralkyl, aryl, alkoxy, substituted alkoxy, cycloalkyl or halo; R3 is hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, aralkyl, aryl, cycloalkyl or cycloalkylalkyl; R4 is alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, aralkyl, aryl, cycloalkyl, cycloalkylalkyl or cycloalkenyl; n is an integer from 0 to 2. Also described is a pharmaceutical composition comprising the compound of Formula I. The compound of Formula I is useful for the treatment or prophalaxis of a neurodegenerative disease, autoimmune disease or  inflammatory disease.
Patent NZ-511830-A (NZ)
Title: Security document with raised intaglio printed image
Inventor: NEMETH JOSHUA ROBERT
IPC: B42D25/29
Filed: 2000-07-05
Abstract: A security document or other device including a substrate (2), a smooth highly reflective layer (1) applied thereto and having a reflectivity of at least 60 gloss units, and a raised printed image (3) applied to said reflective layer by a printing process such as the gravure process, the raised printed image having a height of at least 10 microns and being printed using a translucent ink having a large value of 85 to 95, as measured on an XL 211Hazegard haze measuring instrument, which render it substantially transparent or translucent while causing scattering of the light reflectance and transmittance in at least a partially specular manner. A method of producing a document is also disclosed.
Patent NZ-513398-A (NZ)
Title: Drinks with the use of seawater and process for producing the same
Inventor: IKEGAMI YOSHINARI
IPC: A23L2/38
Filed: 1999-12-17
Abstract: A process for producing a drink by desalting seawater to separate it into water and a concentrate sufficiently containing essential minerals such as magnesium, calcium and iron and vitamins, etc., and adding to the water either one of the concentrate itself or essential mineral components such as water-soluble magnesium, calcium, iron, etc. separately obtained from a seawater concentrate; and drinks obtained by the method.
Patent NZ-513411-A (NZ)
Title: Isolating a cytoplasmic fraction without impairing the viability of oocytes and embryonic cells
Inventor: JANSEN ROBERT
IPC: C12Q1/68
Filed: 2000-02-23
Abstract: A  method of isolating a cytoplasmic fraction from  an oocytes  or an embryonic cell without impairing the capacity of  the  oocytes or embryonic cell to be fertilized includes the  step  of  releasing  a cytoplasmic  fraction  from  the oocytes  or  embryonic cell which is about 5% of the  volume of  the  oocytes or embryonic cell. The method  can  further comprise  the steps of inserting a releasing means into  the oocytes  of  embryonic  cell,  then  drawing  a  cytoplasmic fraction  into  the  releasing  means  and  withdrawing  the releasing  means  so that the fraction is  isolated  in  the releasing  means. The releasing means may  be  an  injection pipette.  Also  described  is  a  method  for  detecting   a nucleotide  sequence,  polymorphism  or  mutation   in   the mitochondrial  genome  of the mitochondria  located  in  the oocytes  or embryonic cell without impairing its ability  to be  fertilized. This method comprises the steps of isolating a  cytoplasmic fraction that includes mitochondria according to  the  above  method  and  then analyzing  the  nucleotide sequence of the mitochondrial genome for the presence  of  a nucleotide  sequence,  polymorphism  or  mutation   in   the mitochondrial genome.
Patent NZ-513570-A (NZ)
Title: Touch switch with integral control circuit
Inventor: CALDWELL DAVID W
IPC: H03K17/96
Filed: 2000-01-18
Abstract: A  touch  switch  apparatus  (20)  for  detecting  the presence  of  an  object  such as  a  human  appendage,  the apparatus  having  a  touch pad (22)  and  a  local  control circuit  (26)  connected to the touch pad and to  a  control device.  The touch pad preferably includes a first electrode (E1)   and   a  second  electrode  (E2)  spaced   from   and surrounding  the first electrode. The control  circuit  (26) is  preferably  in  integrated circuit  form.  A  signal  is provided  to  the  touch pad (22) to  generate  an  electric field  thereabout. Introduction of a stimulus near the touch pad  (22)  disturbs the electric field. The control  circuit detects  the  electric field disturbance in and generates  a control signal in response.
Patent NZ-519587-A (NZ)
Title: Fibre processing apparatus with pins sequentially inserted to increase relative speed after insertion
Inventor: RUSSELL THURLOW
IPC: D01G9/06
Filed: 2000-12-15
Abstract: An apparatus (1) and method is disclosed for fibre processing, in particular, for opening and drafting fibres. The apparatus includes a device (2) having a series of pins (7) coupled to a drive mechanism (8) and arranged for sequential insertion in a feed path (6) along which the fibres are passed, the mechanism being arranged to increase the relative speed between the pins after insertion, to open and draft the fibres.
Patent NZ-521277-A (NZ)
Title: Multiple tags of double thickness, printable with a thermal transfer printer for marking of electrotechnical and/or electronic elements
Inventor: PIANA IVANA
IPC: B31D1/00
Filed: 2002-09-11
Abstract: Printed tags for labelling electronic elements. The tags are formed by die cutting a thin continuous sheet (2) of printed calendared material such that two lateral strips (3) of opposing tags are formed that join in the centre. The sheet may then be folded in two such that the two opposing tags form a single tag of double thickness with markings on each outer surface. The double-sided tag may then be inserted into a suitable support device.
Patent NZ-522221-A (NZ)
Title: Method for producing a container having a pressure compensation opening, and container produced according to said method
Inventor: KUEHN TORSTEN
IPC: B65D1/02
Filed: 2001-03-14
Abstract: A method for producing a container (1) that comprises an outer container (2), an inner pouch (34) disposed therein, and a pressure compensation opening (10) provided in the outer container (2). The invention also relates to a container (1) produced by the inventive method. A preform consisting of two coaxial tubes is produced by a coextrusion blow-molding method using a blow mold, whereby a bottom seam (5) is produced that protrudes outwardly. The aim of the invention is to provide a method by which a container (1) is provided with a pressure compensation opening (10) in the outer container (2) without impairing the tightness of the container (1) while reducing the reject rate and increasing productivity. To this end, the bottom seam (5) is partially cut away and a force is applied on the preform that still has a temperature of 40 DEG C to 70 DEG C, said force acting in the direction of the seam. Said force breaks up the bottom seam (5) and plastically deforms it so that a pressure compensation opening (10) is formed in the bottom area (4).
Patent NZ-523260-A (NZ)
Title: Method and system for health assessment and monitoring
Inventor: WARE JOHN E
IPC: G16H10/60
Filed: 2001-06-04
Abstract: A method of assessing the health status of a patient which is practised on a computer or over a network. The method consists of a series of tests made up of a number of "Testlets", each Testlet being one or more questions relating to an aspect or condition ("Domain") perceived or experienced by the subject. Within a Testlet, the system first identifies the test subject and test session, and also identifies the group of questions relating to the specific Domain. The system then displays a Testlet question (304) with its possible responses on a device. The device receives the response (306) to the displayed question and the system evaluates the response (308) by comparison with statistical data. Finally, the system evaluates the statistical probability of a specific condition of the test subject and compares it against an established threshold limit (310). If the limit has been satisfied, the system may exit the Testlet (312). Otherwise the process returns to step 304 and repeats until the threshold is reached.
Patent NZ-524606-A (NZ)
Title: Sealing cap for ostomy stoma
Inventor: CLINE JOHN
IPC: A61F5/448
Filed: 2003-03-07
Abstract: A flexible membrane (10) is situated within a rigid or semi-rigid cap (B). The edge of the cap wall is adhesively fixed to the issue surrounding the stoma. The interior of the cap is pressurized to press the membrane to seal the stoma against the discharge of solid and semi-solid waste. Gas escapes through a vent with a filter element. The cap can be pressurized by an external pump (38) or an integral pump member situated on top of the cap. A relief valve prevents over pressurization. A collection pouch can be provided as part of a device. The device can be removably mounted on a standard two-piece faceplate.
Patent NZ-528764-A (NZ)
Title: Method for detecting a wind energy plant's temperature or moisture to overcome the generator dampness
Inventor: WOBBEN ALOYS
IPC: F03D80/00
Filed: 2002-04-12
Abstract: A method and apparatus of controlling a temperature of a generator in a wind energy plant or wind power installation having a generator and electrically sensitive parts is disclosed. The method includes the following steps: (a) detecting at least one ambient condition in the wind power installation with sensors (22,24), and (b) heating the generator according to the detected ambient condition. Detecting the ambient condition includes detecting at least one of a temperature difference between the temperature of the generator and the temperature of the air in the surroundings of the wind power installation, and detecting a moisture deposit on parts of the generator or other electrically sensitive parts of the wind power installation. The generator is heated if at least one of the temperature difference is negative and the moisture deposit is above a predetermined value. The generator is heated by short-circuiting the generator stator (10) and applying a predeterminable exciter current to the generator rotor (12), where the generator is heated for a predetermined period of time to a temperature exceeding the surrounding air.
Patent NZ-535454-A (NZ)
Title: An electrochemical apparatus incorporating an electrode for the reduction of polysulfide species
Inventor: FLETCHER STEPHEN
IPC: H01M8/02
Filed: 2003-03-26
Abstract: Disclosed is an electrochemical apparatus which comprises a single cell or an array of cells, each cell with a positive chamber containing a positive electrode and an electrolyte solution and a negative chamber containing a negative electrode and an electrolyte solution containing sulfide, wherein: the redox couple of the positive chamber differs from the redox couple of the negative chamber; the positive and negative chambers are separated from one another by a cation exchange membrane; and the negative electrode is an electrode which incorporates therein a polysulfide species reduction catalyst, which catalyst comprises at least one organic complex of a transition metal.
Patent NZ-538470-A (NZ)
Title: Supplying water to a reticulation system from different sources
Inventor: GRAY IAN
IPC: E03B1/04
Filed: 2003-09-01
Abstract: A combined tank storage and mains water supply for a building 11 includes a tank 13 to collect water from the roof and gutters 10, 12 of the building, a sensor 21 to detect the level of water in the tank, a water supply system to supply water from the tank including a water pump 23 to pump the water from the tank into the supply system, a non-return valve 25 downstream of the pump, and a pressure sensor 26 downstream of the valve. After the pressure sensor the supply system is connected to input port 34 of a three-port valve 35, a second port 37 of which is connected to the mains water supply 38, 39, and the third port 41 of which is connected to the water reticulation system for the building. The valve operates so that when the first and third ports are open the second port is closed and when the second and third ports are open the first port is closed. A controller 27 receives inputs from the water level sensor, the pressure sensor, and mains electricity supply and controls the operation of the water pump and three-port valve.
Patent NZ-543359-A (NZ)
Title: Benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: DESOS PATRICE
IPC: C07D417/12
Filed: 2005-11-02
Abstract: Benzothiadiazine compounds of formula (I), their enantiomers and diastereoisomers, and also addition salts thereof with a pharmaceutically acceptable acid or base are disclosed, wherein: X represents an oxygen or sulphur atom; R1 represents a linear or branched (C1-C6)alkyl group substituted by one or more halogen atoms; R2 represents a hydrogen atom, a halogen atom or a hydroxy group; R3 represents a group R4 or -Y-R5 wherein R4 represents a linear or branched (C1-C6)alkyl group optionally substituted by an aryl group; a linear or branched (C2-C6)alkenyl group optionally substituted by an aryl group; a linear or branched (C1-C6)polyhaloalkyl group; a (C1-C6)cycloalkyl group; an adamantyl group; an aryl group; or a heteroaryl group, Y represents an oxygen or sulphur atom or an NR group wherein R represents a hydrogen atom or a linear or branched (C1-C6)alkyl group, and R5 may take any of the meanings of R4. These benzothiadiazine compounds and their pharmaceutical compositions are used for manufacturing a medicament for use as AMPA modulators.
Patent NZ-548871-A (NZ)
Title: Use of arylsulfatase A for treating metachromatic leukodystrophy
Inventor: FOGH JENS
IPC: C12N9/16
Filed: 2005-01-30
Abstract: Disclosed is the use of a formulation comprising an effective amount of arylsulfatase A for the manufacture of a medicament for reducing the levels of galactosyl sulphatide in cells within the central nervous system in a subject suffering from and/or being diagnosed with metachromatic leukodystrophy, wherein said formulation is to be administered by intravenous or subcutaneous administration.
Patent NZ-550732-A (NZ)
Title: Polyamide multilayer film
Inventor: BEKELE SOLOMON
IPC: C08G69/48
Filed: 2005-04-21
Abstract: The disclosure relates to a multilayer film comprising: A first layer comprising at least about 40% of one or more modified polyamides, based on the weight of the first layer; A second layer comprising at least about 40% of one or more unmodified polyamides, based on the weight of the second layer; and a third layer comprising at least about 40% of one or more tie polymers selected from ethylene/vinyl acetate copolymer, ethylene/(meth)acrylic acid copolymer, ethylene/C1-C12 alkyl (meth)acrylate copolymer, and anhydride-modified polyolefin, based on the weight of the third layer; wherein the second layer is directly adhered to the first and third layers.